MIP-1 γ Antibodies

Santa Cruz Biotechnology delivers a wide array of MIP-1 γ monoclonal antibodies for research focused on understanding this important chemokine. MIP-1 γ Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). MIP-1 γ, also known as CCL9, is a chemokine that drives immune cell recruitment to inflammation sites and plays a vital role in immune response regulation. Research has shown MIP-1 γ's significance in cancer progression and autoimmune conditions through its influence on leukocyte behavior. Understanding MIP-1 γ functions opens new possibilities for developing targeted therapeutic strategies. Researchers can utilize specific detection methods to track MIP-1 γ expression patterns across different tissue types and experimental conditions. Advanced visualization techniques help reveal the distribution and dynamics of MIP-1 γ in cellular processes. Multiple conjugation options are available, including horseradish peroxidase (HRP), phycoerythrin (PE), and fluorescein isothiocyanate (FITC), allowing flexibility in experimental design. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing our understanding of immune system regulation and disease mechanisms.